Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC

Metformin is used to treat diabetes and its use has been associated with reduced cancer incidence, but the mechanism is unclear. In this study, metformin is shown to alter microRNA expression including an increase in mir-33a, which decreases the expression of the oncogene c-Myc.